Brown Advisory Inc. Invests $209,000 in Tempus AI, Inc. (NASDAQ:TEM)

Brown Advisory Inc. bought a new position in Tempus AI, Inc. (NASDAQ:TEM) in the first quarter, according to the company in its most recent 13F filing with the SEC. The firm bought 4,338 shares of the company’s stock, valued at approximately $209,000.

A number of other institutional investors have also modified their holdings of the stock. Franklin Resources Inc. boosted its holdings in Tempus AI by 240.5% in the 4th quarter. Franklin Resources Inc. now owns 2,762,173 shares of the company’s stock worth $93,251,000 after buying an additional 1,950,862 shares during the last quarter. JPMorgan Chase & Co. lifted its holdings in Tempus AI by 86,947.2% in the fourth quarter. JPMorgan Chase & Co. now owns 1,653,896 shares of the company’s stock valued at $55,836,000 after acquiring an additional 1,651,996 shares during the last quarter. Norges Bank acquired a new position in Tempus AI in the fourth quarter valued at approximately $34,681,000. Sumitomo Mitsui Trust Group Inc. raised its position in Tempus AI by 31.4% in the first quarter. Sumitomo Mitsui Trust Group Inc. now owns 4,255,477 shares of the company’s stock valued at $205,284,000 after purchasing an additional 1,016,384 shares during the period. Finally, Mariner LLC purchased a new stake in Tempus AI in the fourth quarter valued at approximately $31,187,000. Hedge funds and other institutional investors own 24.22% of the company’s stock.

Tempus AI Stock Up 7.3%

Shares of NASDAQ TEM opened at $59.97 on Thursday. Tempus AI, Inc. has a 1 year low of $31.36 and a 1 year high of $91.45. The firm’s 50 day moving average price is $63.15 and its 200 day moving average price is $55.27. The firm has a market cap of $10.38 billion and a P/E ratio of -7.69. The company has a debt-to-equity ratio of 2.45, a quick ratio of 1.56 and a current ratio of 1.71.

Tempus AI (NASDAQ:TEM) last announced its quarterly earnings results on Tuesday, May 6th. The company reported ($0.24) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.27) by $0.03. Tempus AI had a negative net margin of 88.27% and a negative return on equity of 533.21%. The firm had revenue of $255.74 million during the quarter, compared to analysts’ expectations of $248.13 million. Tempus AI’s revenue for the quarter was up 75.4% on a year-over-year basis. As a group, sell-side analysts anticipate that Tempus AI, Inc. will post -6.15 earnings per share for the current year.

Analyst Ratings Changes

A number of analysts have recently weighed in on the company. Piper Sandler upped their price objective on Tempus AI from $55.00 to $70.00 and gave the stock a “neutral” rating in a research report on Thursday, May 15th. Guggenheim increased their target price on shares of Tempus AI from $65.00 to $75.00 and gave the stock a “buy” rating in a research note on Monday, June 30th. BTIG Research started coverage on shares of Tempus AI in a report on Monday, April 21st. They set a “buy” rating and a $60.00 price target for the company. Morgan Stanley increased their target price on shares of Tempus AI from $60.00 to $65.00 and gave the company an “overweight” rating in a report on Friday, May 9th. Finally, Needham & Company LLC reaffirmed a “buy” rating and issued a $70.00 target price on shares of Tempus AI in a report on Wednesday, May 7th. Six equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, Tempus AI has a consensus rating of “Moderate Buy” and an average target price of $65.09.

Insider Transactions at Tempus AI

In related news, CEO Eric P. Lefkofsky sold 250,000 shares of the business’s stock in a transaction dated Tuesday, June 17th. The shares were sold at an average price of $70.07, for a total transaction of $17,517,500.00. Following the completion of the sale, the chief executive officer owned 9,357,283 shares of the company’s stock, valued at $655,664,819.81. This represents a 2.60% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, COO Ryan Fukushima sold 20,000 shares of the business’s stock in a transaction dated Tuesday, May 6th. The shares were sold at an average price of $52.36, for a total transaction of $1,047,200.00. Following the sale, the chief operating officer directly owned 884,460 shares of the company’s stock, valued at approximately $46,310,325.60. This represents a 2.21% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 612,522 shares of company stock worth $41,600,238 over the last three months. Insiders own 27.60% of the company’s stock.

Tempus AI Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.